Projects per year
Personal profile
Personal profile
After serving as a Research Assistant in the Department of Statistics and Actuarial Science at the University of Waterloo, Dr. Xu received her academic appointment in 2003 as an Assistant Professor in the Center of American Indian Health Research of the College of Public Health at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma. She joined Houston Methodist Research Institute in 2007. Dr. Xu is an Associate Research Professor of Biostatistics in the Center for Outcomes Research and Houston Methodist DeBakey Heart & Vascular Center at Houston Methodist Research Institute.
Research interests
Dr. Xu’s biostatistics work has primarily focused on cardiovascular disease (CVD), diabetes, renal disease, and cancer. She was the biostatistician for the NIH-funded Strong Heart Study, the largest and longest longitudinal study of cardiovascular disease and its risk factors in American Indians.
Dr. Xu’s current biostatistics studies include NIH and DoD-funded studies in brain metastatic tumors and breast cancer.
Education/Academic qualification
Statistics, PhD, University of Waterloo, Canada
Jul 1 1999 → Jun 30 2003
Statistics, MS, York University, Toronto, Canada
Jul 1 1998 → Jun 30 1999
BSc, Sichuan University
Jul 1 1982 → Jun 30 1986
Research Area Keywords
- Outcomes, Quality & Health Care Performance
- Systems Medicine & Bioinformatics
Free-text keywords
- Biostatistics
- Clinical trial data analysis
- Survival data analysis
- Longitudinal data analysis
- Cardiovascular disease
- Diabetes
- Kidney disease
- Nutrition
Fingerprint
Dive into the research topics where Susan Xu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Nanotechnology-based targeting of breast cancer liver metastases
Godin, B., Chen, S., Niravath, P. A., Rosato, R. R. & Xu, S.
3/1/21 → 2/28/25
Project: Federal Funding Agencies
-
Real-world experience with Tecentriq + Avastin for the treatment of hepatocellular carcinoma (HCC) in the US
Abdelrahim, M., Connor, A. A., Dacha, S., Divatia, M. K., Esmail, A., Esnaola, N. F., Ghobrial, R. M., Graviss, E. A., Gupta, N., Heyne, K., Hobeika, M. J., Kloc, M., Kodali, S., Mobley, C. M., Moore, L. W., Noureddin, M., Rizk, E., Victor, III, D. W. & Xu, S.
Project: Clinical Trial
-
Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation
Riveros, C., Ranganathan, S., Haque, W., Huang, E., Xu, J., Kulkarni, G. S., Geng, M., Anis, M., Muhammad, T., Chan, K. S., Farach, A., Teh, B. S., Miles, B. J., Klaassen, Z., Sonpavde, G. P., Wallis, C. J. D. & Satkunasivam, R., Feb 2024, In: Journal of the Canadian Urological Association. 18, 2, p. 17-24 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Prevalence of Delirium After Abdominal Surgery and Association With Ketamine: A Retrospective, Propensity-Matched Cohort Study
Faisal, H., Qamar, F., Hsu, E. S., Xu, J., Lai, E. C., Wong, S. T. & Masud, F. N., Jan 11 2024, In: Critical care explorations. 6, 1, p. E1032Research output: Contribution to journal › Article › peer-review
Open Access -
1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC)
Wiechmann, C., Gee, K., Burns, E. A., Xu, J., Zhang, Y., Crenshaw, A., Esmail, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Efstathiou, E. & Abdelrahim, M., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1360-A1360Research output: Contribution to journal › Article › peer-review
-
1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)
Gee, K., Wiechmann, C., Burns, E. A., Xu, J., Zhang, Y., Esmail, A., Crenshaw, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1361-A1361Research output: Contribution to journal › Article › peer-review
-
451 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving Atezolizumab
Xu, J., Burns, E. A., Gee, K., Wiechmann, C., Zhang, Y., Kieser, R. B., Umoru, G., Shah, S., Sun, K., Abdelrahim, M. & Esmail, A., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A502-A502Research output: Contribution to journal › Article › peer-review